Figure 3 from Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive Capacity
Year: 2024
Type: other
Abstract: KD of TDO2 can increase IDO1 expression and activity in a compensatory manner. Stable genetic KD TDO2 (shTDO2) or scramble control (shSCR) in BT549 cells. A, Immunoblot of TDO2 and IDO1. B, Catabolite level shown in peak area (mean ± SEM) of formyl-KYN and KYN as measured by steady-state metabolomics in conditioned media from BT549 with shTDO2 or shSCR control. C, Activated AhR-regulated genes CYP1A1 and CYP1B1 with and without shTDO2. Data are displayed as mean ± SD with one-way ANOVA analysis. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.
Language: English
Subfield: Biological Psychiatry
Field: Neuroscience
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4403468203
